Antiparkinson drug - Mucuna pruriens shows antioxidant and metal chelating activity

Phytotherapy Research

Volumn 22, Issue 1, 2008, Pages 6-11

  Dhanasekaran, Muralikrishnan ^a   Tharakan, Binu ^b   Manyam, Bala V ^b,c,d  

^a AUBURN UNIVERSITY   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Deoxyribose sugar damage; Iron chelation; Lipid peroxidation; Mucuna pruriens; Parkinson's disease

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ANTIPARKINSON AGENT; DEOXYRIBOSE; LIPID; MUCUNA PRURIENS EXTRACT; PLANT EXTRACT; PLASMID DNA; RADICAL; REACTIVE OXYGEN METABOLITE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; COTYLEDON; DISEASE COURSE; DRUG INHIBITION; DRUG SAFETY; GENOTOXICITY; IRON CHELATION; LIPID PEROXIDATION; MALE; MUTAGENIC ACTIVITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; POWDER; RAT; VELVET BEAN;

ANIMALS; ANTIOXIDANTS; ANTIPARKINSON AGENTS; BRAIN; CHELATING AGENTS; COTYLEDON; DNA DAMAGE; FLAVONOIDS; FREE RADICAL SCAVENGERS; GLUTATHIONE; LIPID PEROXIDATION; MALE; MUCUNA; OXIDATIVE STRESS; PHENOLS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

ANIMALIA; MUCUNA PRURIENS;

EID: 38549134407     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2109     Document Type: Article

References (31)

1. Alam ZI, Jenner A, Daniel SE et al. 1997. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69: 1196-1203.
2. Ambani LM, Van Woert MH, Murphy S. 1975. Brain peroxidase and catalase in Parkinson's disease. Arch Neurol 32: 114-118.
3. Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD. 1999. Dietary factors in Parkinson's disease: the role of food groups and specific foods. Mov Disord 14: 21-27.
4. Banaclocha M. 2000. N-Acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice: implications for treatment of Parkinson's disease. Brain Res 859: 173-175.
5. Barzilai A, Yamamoto K. 2004. DNA damage responses to oxidative stress. DNA Repair (Amst) 3: 1109-1115.
6. Cohn VH, Lyle J. 1966. A fluorometric assay for glutathione. Anal Biochem 14: 434-440.
7. de Carvalho MC, Barca FN, Agnez-Lima LF, de Medeiros SR. 2003. Evaluation of mutagenic activity in an extract of pepper tree stem bark (Schinus terebinthifolius Raddi). Environ Mol Mutagen 42: 185-191.
8. Dexter DT, Carter CJ, Wells FR et al. 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381-389.
9. Dexter DT, Wells FR, Agid F et al. 1987. Increased nigral iron content in postmortem parkinsonian brain. Lancet ii: 1219-1220.
10. Ferreira-Machado SC, Rodrigues MP, Nunes AP et al. 2004. Genotoxic potentiality of aqueous extract prepared from Chrysobalanus icaco L. leaves. Toxicol Lett 151: 481-487.
11. Halliwell B, Gutteridge JMC. 1981. Formation of a thiobarbituric-acid- reactive substance from deoxyribose in the presence of iron salts. FEBS Lett 128: 347-352.
12. HP-200 in Parkinson's Disease Study Group (Manyam BV, Principal Investigator and Senior Author). 1995. HP-200: an 'alternative medicine' treatment for Parkinson's disease. J Altern Complement Med 1: 249-255.
13. Hussain G, Manyam BV. 1997. Mucuna pruriens proves more effective than L-DOPA in Parkinson's disease animal model. Phytother Res 11: 419-423.
14. Jenner P, Olanow CW. 1998. Understanding cell death in Parkinson's disease. Ann Neurol 44: S72-S84.
15. Lahiri M, Maru GB, Bhide SV. 1993. Effect of plant phenols, beta-carotene and alpha-tocopherol on benzo[a]pyrene-induced DNA damage in the mouse fore stomach mucosa (target organ) and bone marrow polychromatic erythrocytes (non-target organ). Mutat Res 303: 97-100.
16. Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S. 2001. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 78: 1073-1082.
17. Malterud KE, Farbrot TL, Huse AE, Sund RB. 1993. Antioxidant and radical scavenging effects of anthraquinones and anthrones. Pharmacology 47: 77-85.
18. Manyam BV, Dhanasekaran M, Hare T. 2004. Neuroprotective effects of antiparkinson drug Mucuna pruriens. Phytother Res 18: 706-712.
19. Manyam BV, Parikh KM. 2003. Antiparkinsonian activity of Mucuna pruriens seeds. Ann Neurosci 9: 40-46.
20. Matsuda H, Murakami T, Kishi A, Yoshikawa M. 2001. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg Med Chem 9: 1499-1507.
21. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. 1993. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 84: 407-412.
22. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
23. Opoku AR, Maseko NF, Terblanche SE. 2002. The in vitro antioxidative activity of some traditional Zulu medicinal plants. Phytother Res 16: 51-56.
24. Perry TL, Godin DV, Hansen S. 1982. Parkinson's disease: A disorder due to nigral glutathione deficiency? Neurosci Lett 33: 305-310.
25. Rao PV, Maddala R, John F, Zigler JS Jr. 2004. Expression of nonphagocytic NADPH oxidase system in the ocular lens. Mol Vis 10: 112-121.
26. Saggu H, Cooksey J, Dexter D et al. 1989. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 53: 629-692.
27. Shahidi F. 2000. Antioxidants in food and food antioxidants. Nahrung 44: 158-163.
28. Shanmugasundaram KR, Ramanujam S, Shanmugasundaram ER. 1994. Amrita Bindu - a salt-spice-herbal health food supplement for the prevention of nitrosamine induced depletion of antioxidants. J Ethnopharmacol 42: 83-93.
29. Swain T, Hillis WE. 1959. Phenolic constituents of Prunus domestica. J Sci Food Agric 10: 63-68.
30. Taylor JL, Elgorashi EE, Maes A et al. 2003. Investigating the safety of plants used in South African traditional medicine: Testing for genotoxicity in the micronucleus and alkaline comet assays. Environ Mol Mutagen 42: 144-154.
31. Yoshikawa T. 1993. Free radicals and their scavengers in Parkinson's disease. Eur Neurol 33: 60-68.